Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Nitto BioPharma | Leaders in Drug |
Description | Nitto BioPharma, Nitto BioPharma, Inc. | San Diego, CA Contact Nitto Global Nitto BioPharma, Inc. Home About Us Technology Pipeline Careers Press Releases Leadership in Dr |
Keywords | N/A |
WebSite | nittobiopharma.com |
Host IP | 216.55.149.9 |
Location | United States |
Site | Rank |
US$4,424,366
Last updated: 2023-05-13 09:05:54
nittobiopharma.com has Semrush global rank of 2,392,276. nittobiopharma.com has an estimated worth of US$ 4,424,366, based on its estimated Ads revenue. nittobiopharma.com receives approximately 510,504 unique visitors each day. Its web server is located in United States, with IP address 216.55.149.9. According to SiteAdvisor, nittobiopharma.com is safe to visit. |
Purchase/Sale Value | US$4,424,366 |
Daily Ads Revenue | US$4,085 |
Monthly Ads Revenue | US$122,521 |
Yearly Ads Revenue | US$1,470,251 |
Daily Unique Visitors | 34,034 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nittobiopharma.com. | A | 86400 | IP: 216.55.149.9 |
nittobiopharma.com. | NS | 86400 | NS Record: ns1.att-websites.com. |
nittobiopharma.com. | NS | 86400 | NS Record: ns2.att-websites.com. |
nittobiopharma.com. | MX | 86400 | MX Record: 10 mx1c45.carrierzone.com. |
nittobiopharma.com. | MX | 86400 | MX Record: 100 mx2c45.carrierzone.com. |
nittobiopharma.com. | MX | 86400 | MX Record: 120 mx4c45.carrierzone.com. |
nittobiopharma.com. | MX | 86400 | MX Record: 110 mx3c45.carrierzone.com. |
nittobiopharma.com. | TXT | 86400 | TXT Record: google-site-verification=xJZQk6lP4BvwRMRcD4xwQn3mmmj2Y5UcNUyIKgTkcVQ |
nittobiopharma.com. | TXT | 86400 | TXT Record: v=spf1 a mx include:spfc45.carrierzone.com ~all |
Nitto BioPharma, Inc. | San Diego, CA Contact Nitto Global Nitto BioPharma, Inc. Home About Us Technology Pipeline Careers Press Releases Leadership in Drug Delivery Nitto BioPharma Inc. (NBPI) offers unique drug and siRNA delivery solutions by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the cells. Leadership in Fibrosis NBPI is developing a first-in-class drug for the treatment of fibrotic diseases of the liver and of other organs. The first clinical indication being tested is liver cirrhosis, or scarring of the liver, an incurable disease which afflicts 6 million people worldwide. what’s new / view all press releases Nitto announces Phase I clinical trial of NBF-006 for the treatment of KRAS driven tumors in advanced cancer patients is allowed to proceed by the FDA / 2018/Nov/29 Nitto Denko Corporation (Headquarters: Osaka, Japan; President, CEO & COO: Hideo Takasaki; “Nitto”, |
HTTP/1.1 301 Moved Permanently Date: Tue, 21 Dec 2021 03:06:06 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 235 Connection: keep-alive Content-Security-Policy: upgrade-insecure-requests; Location: https://nittobiopharma.com/ HTTP/2 200 date: Tue, 21 Dec 2021 03:06:07 GMT content-type: text/html; charset=UTF-8 content-security-policy: upgrade-insecure-requests; strict-transport-security: max-age=15768000 |
Domain Name: NITTOBIOPHARMA.COM Registry Domain ID: 2021733464_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2019-04-11T20:32:28Z Creation Date: 2016-04-14T22:51:03Z Registry Expiry Date: 2022-04-14T22:51:03Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.ATT-WEBSITES.COM Name Server: NS2.ATT-WEBSITES.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T07:50:51Z <<< |